Page last updated: 2024-11-08

dimethylphenylpiperazinium iodide and Muscular Atrophy

dimethylphenylpiperazinium iodide has been researched along with Muscular Atrophy in 1 studies

Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.

Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WEIS, J1

Other Studies

1 other study available for dimethylphenylpiperazinium iodide and Muscular Atrophy

ArticleYear
Biphasic response of guinea-pig's taenia coli induced by 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP).
    Acta pharmacologica et toxicologica, 1962, Volume: 19

    Topics: Colon; Dimethylphenylpiperazinium Iodide; Ganglionic Blockers; Guinea Pigs; Iodides; Muscular Atroph

1962